v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Deficit
Noncontrolling Interest
Series A-1 Preferred
Preferred Stock
Series S-1 Preferred
Preferred Stock
Series B Preferred
Series B Preferred
Preferred Stock
Series I Preferred
Preferred Stock
Series M Preferred
Series M Preferred
Preferred Stock
Series Q Preferred
Preferred Stock
Series V Preferred
Preferred Stock
Beginning balance (in shares) at Dec. 30, 2023             193,730 100,000              
Beginning balance at Dec. 30, 2023 $ (3,308) $ 3 $ 47,323 $ (50,634)     $ 0 $ 0              
Beginning balance (in shares) at Dec. 30, 2023   4,957,647                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Share based compensation 345   345                        
Reclassification of Series S stock to liability (339)   (339)                        
Reclassification of Series S stock to permanent equity 7,993                            
Common stock issued for equity financing (in shares)   884,880                          
Common stock issued for equity financing $ 627 $ 1 626                        
Common stock issued for consulting agreement (in shares) 0 200,000                          
Common stock issued for consulting agreement $ 232   232                        
Common stock issued in lieu of note payable obligations (in shares)   600,000                          
Common stock issued in lieu of note payable obligations 367 $ 1 366                        
Common stock issued for RSU's granted (in shares)   908,852                          
Net income (loss) (2,144)     (2,144)                      
Ending balance (in shares) at Mar. 30, 2024             193,730 100,000              
Ending balance at Mar. 30, 2024 3,773 $ 5 48,553 (52,778)     $ 0 $ 0              
Ending balance (in shares) at Mar. 30, 2024   7,551,379                          
Beginning balance (in shares) at Dec. 30, 2023             193,730 100,000              
Beginning balance at Dec. 30, 2023 (3,308) $ 3 47,323 (50,634)     $ 0 $ 0              
Beginning balance (in shares) at Dec. 30, 2023   4,957,647                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Reclassification of Series S stock to permanent equity 8,000                            
Ending balance (in shares) at Dec. 28, 2024             23,480 100,000 34,207 34,207 17,000 3,200 3,200 925,212 5,000
Ending balance at Dec. 28, 2024 $ 24,811 $ 9 62,207 (56,879) $ (2,317) $ 3,925 $ 0 $ 0   $ 8,552 $ 0   $ 0 $ 1,321 $ 0
Ending balance (in shares) at Dec. 28, 2024 15,417,693 15,417,693                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common stock issued for warrants exercised (in shares)   45,455                          
Common stock issued for warrants exercised $ 78   78                        
Common stock issued for Series V Preferred converted (in shares)   600,000                         (5,000)
Common stock issued for consulting agreement (in shares) 0 15,499                          
Common stock issued for consulting agreement $ 94   94                        
Foreign currency adjustment 3,633       3,633                    
Net income (loss) (3,286)     (2,861)   (425)                  
Ending balance (in shares) at Mar. 29, 2025             23,480 100,000 34,207 34,207 17,000 3,200 3,200 925,212 0
Ending balance at Mar. 29, 2025 $ 25,330 $ 9 $ 62,379 $ (59,740) $ 1,316 $ 3,500 $ 0 $ 0   $ 8,552 $ 0   $ 0 $ 1,321 $ 0
Ending balance (in shares) at Mar. 29, 2025 16,078,647 16,078,647